盟科药业：公司药品康替唑胺片获批准新增受托生产企业

Core Viewpoint - The company has received approval from the National Medical Products Administration for the drug "Kangti Zuoan Tablets," marketed as "Youxitai," allowing Jiangsu Xuantai Pharmaceutical Co., Ltd. to act as a contract manufacturer [1] Group 1 - The approval includes the use of raw materials from Chongqing Boten Pharmaceutical Technology Co., Ltd. for the commercial production of Kangti Zuoan Tablets [1] - The company has also initiated additional clinical trials for the MRX-5 Tablets in a new 200mg specification, targeting infections caused by non-tuberculous mycobacteria sensitive to this product [1]